Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study
- Publication date
- 13 February 2022
- Publisher
- 'Springer Science and Business Media LLC'